03

2008

-

07

Huaier granules for new packaging!


On January 29, 2008, the State Food and Drug Administration formally approved the application of Huaier Granules to increase the function of traditional Chinese medicine. The indications are lung cancer, breast cancer, gastric cancer, and colorectal cancer on the basis of the original primary liver cancer. Four diseases. According to the regulations of the State Food and Drug Administration on the management of drug packaging labels, the company has adjusted the packaging of Huaier granules since March 17, 2008 (batch number HC17), with the original specifications and prices unchanged. Old packaged drugs can continue to be used during the validity period.